Loncar Cancer Immunotherapy ETF (CNCR)
The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. At least 80% of its total assets will be invested in the component securities of the index. The fund is non-diversified.
$13.36M
Oct 13, 2015
$0.00
0.00
0.00
21.98%
0.00%
0.00
0.00
0.00
0.00
0.00%
0.00%
Sector weights (11)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Staples Select Sector SPDR Fund
XLP
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (20)
Instil Bio, Inc.
TIL
3.591%
Replimune Group, Inc.
REPL
3.541%
Iovance Biotherapeutics, Inc.
IOVA
3.471%
Bristol-Myers Squibb Company
BMY
3.391%
Nektar Therapeutics
NKTR
3.371%
Merck & Co., Inc.
MRK
3.371%
Regeneron Pharmaceuticals, Inc.
REGN
3.361%
Gilead Sciences, Inc.
GILD
3.331%
Fate Therapeutics, Inc.
FATE
3.331%
Arcus Biosciences, Inc.
RCUS
3.321%
Atara Biotherapeutics, Inc.
ATRA
3.301%
Allogene Therapeutics, Inc.
ALLO
3.291%
ImmunityBio, Inc.
IBRX
3.281%
bluebird bio, Inc.
BLUE
3.281%
Shattuck Labs, Inc.
STTK
3.231%
IGM Biosciences, Inc.
IGMS
3.231%
ALX Oncology Holdings Inc.
ALXO
3.211%
Legend Biotech Corporation
LEGN
3.201%
BeiGene, Ltd.
BGNE
3.191%
MacroGenics, Inc.
MGNX
3.171%
Sector weights (11)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Staples Select Sector SPDR Fund
XLP
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (20)
Instil Bio, Inc.
TIL
3.591%
Replimune Group, Inc.
REPL
3.541%
Iovance Biotherapeutics, Inc.
IOVA
3.471%
Bristol-Myers Squibb Company
BMY
3.391%
Nektar Therapeutics
NKTR
3.371%
Merck & Co., Inc.
MRK
3.371%
Regeneron Pharmaceuticals, Inc.
REGN
3.361%
Gilead Sciences, Inc.
GILD
3.331%
Fate Therapeutics, Inc.
FATE
3.331%
Arcus Biosciences, Inc.
RCUS
3.321%
Atara Biotherapeutics, Inc.
ATRA
3.301%
Allogene Therapeutics, Inc.
ALLO
3.291%
ImmunityBio, Inc.
IBRX
3.281%
bluebird bio, Inc.
BLUE
3.281%
Shattuck Labs, Inc.
STTK
3.231%
IGM Biosciences, Inc.
IGMS
3.231%
ALX Oncology Holdings Inc.
ALXO
3.211%
Legend Biotech Corporation
LEGN
3.201%
BeiGene, Ltd.
BGNE
3.191%
MacroGenics, Inc.
MGNX
3.171%